Ignite Creation Date:
2024-05-06 @ 1:15 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03970837
Status:
TERMINATED
Last Update Posted:
2023-11-30
First Post:
2019-05-16
Brief Title:
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic csBiologic b Disease Modifying Anti-rheumatic Drugs DMARDs
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline